Sorry, you need to enable JavaScript to visit this website.

For 175 years, patients have trusted Pfizer to discover, develop, and deliver medical breakthroughs that change patients’ lives. Today, we collaborate with patients and patient advocates to help develop breakthrough treatments and innovative approaches to address patient challenges. These partnerships have helped to increase patient engagement in research and development, diversify clinical trials, develop patient-friendly educational materials and patient support programs, and elevate priority policy and social impact issues.

Watch Global Patient Advocacy: All In For All Patients on YouTube.

Here are just a few ways we are living our commitment to putting patients first:

To ensure we meet patient needs, Pfizer aims to listen and learn from patients, acting as partners with accountability and integrity, to deliver outcomes that matter most to patients and those involved in their care. Our collaboration with patient advocacy groups worldwide informs our work, from research and clinical strategies to disease education programs and public policy initiatives.

Pfizer’s Global Patient Advocacy Team leads the enterprise-wide strategy on engagement with patient advocacy groups. With a patient engagement lead based in every region, our team works with all patients and advocates regardless of geography, disease focus or economic status. We have assembled global and national boards of Patient Centricity Advisors who collaborate with colleagues to develop patient-focused programs and resources and build meaningful approaches to measure progress on behalf of patients. Together, we create and nurture sustainable partnerships that measurably improve patient outcomes.

We take an inside-out approach to patient centricity, working to connect every colleague to our commitment to the people we serve. Through internal initiatives, we are fostering a culture of patient centricity across the organization. These initiatives include patient engagement trainings and advocacy workshops. In 2024, we implemented a new corporate policy on interactions with patients and patient advocacy groups to support our commitment to patient centricity and appropriate, ethical engagements.

Patients in Focus is Pfizer’s global celebration of our company-wide dedication to patients. This week-long activation is held every October and features a range of global and local events aimed at deepening our understanding of the needs of patients, advocates, and caregivers around the world. Throughout the week, all colleagues take time to recognize the impact that patients have on our work, renew our commitment to putting them at the center of all we do, and feel the joy that comes with helping others live healthier lives.

The Patient Advocacy Leadership Collective is an innovative hub that provides connectivity, community resources, and a collection of tools focused on sustainable capacity building for patient advocates. Co-created with a Global Patient Advisory Board, the platform is intended to support patient advocacy organizations around the world with leadership training and peer-to-peer mentorship. The Patient Advocacy Leadership Collective empowers those organizations with knowledge and skills provided through evidence-based tools and resources that elevate their work in support of patient communities.

At Pfizer, we work hard to deliver breakthroughs while ensuring patients have all the information they need to have full confidence in their medicines and vaccines. Our teams strive to communicate known product information and instructions and to ensure clinical trial outcomes and data is balanced, accessible, timely, and useful. Pfizer is working in several different areas to make health information easier to understand for patients, including developing plain language summaries of research findings. We also partner with external organizations to evaluate our language around health topics to improve phrasing so that health information is easier to understand.

Our work is not just about our responsibility to our communities, but reflects the enduring belief that better health is possible for everyone, everywhere. As such, our commitment extends to partnering with other stakeholders to provide programs, innovative technologies, educational materials, and more to assist the patient in accessing their prescribed Pfizer medication. Together with our partners and with global health institutions, we are improving healthcare access for underserved people in the U.S. and around the world, creating lasting social impact.